Thomas Hooven, MD, is a physician-scientist with board certification in general pediatrics and neonatology/perinatology. He is the principal investigator of a research program spanning microbiology, bacterial genetics, bioinformatics, and immunology. His current work combines critical care of high-risk infants with basic science and translational laboratory research investigating interactions between microbial pathogens, pregnant mothers, and their babies. His laboratory focuses on understanding infection caused by Streptococcus agalactiae (group B Streptococcus; GBS), an important contributor to newborn morbidity and mortality, and how the neonatal microbiome influences susceptibility to infectious diseases.
Hooven earned his B.A. from Yale University. After graduating from the University of Michigan Medical School, he completed his general pediatrics training at Morgan Stanley Children’s Hospital of New York-Presbyterian in Manhattan, where he also served as chief resident. Following his neonatology fellowship at the same institution, he participated in the Pediatric Scientist Development Program, a three-year mentored research program where he established his research interests in bacterial genetics and host-pathogen interactions that contribute to neonatal illness. He moved to UPMC Children's Hospital of Pittsburgh in 2019.